Antioxidant strategies and respiratory disease of the preterm newborn: An update

Oxidative Medicine and Cellular Longevity

Volumn 2014, Issue , 2014, Pages

  Poggi, Chiara ^a   Dani, Carlo ^a  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL ORGANS; OXYGEN; PULMONARY DISEASES; RESUSCITATION; SURFACE ACTIVE AGENTS; VENTILATION;

ANTI-INFLAMMATORIES; ANTIOXIDANT CAPACITY; ENZYMATIC AND NON-ENZYMATIC ANTIOXIDANTS; INTRAUTERINE INFECTION; MECHANICAL VENTILATION; SINGLE NUCLEOTIDE POLYMORPHISMS; SUPER OXIDE DISMUTASE; TARGETED TREATMENT;

ANTIOXIDANTS;

ANTIOXIDANT; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE; CYCLOSPORIN; DOXYCYCLINE; GLUTATHIONE TRANSFERASE; GUANINE NUCLEOTIDE BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; L SELECTIN; LUNG SURFACTANT; MACROPHAGE MIGRATION INHIBITION FACTOR; MELATONIN; MYELOPEROXIDASE; PLASMALOGEN; PYRROLIDINE DITHIOCARBAMATE; SUPEROXIDE DISMUTASE; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; SURFACTANT;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTIFICIAL VENTILATION; CELL PROLIFERATION; CIRCADIAN RHYTHM; CLINICAL TRIAL (TOPIC); DNA DAMAGE; ENZYME REPLACEMENT; GENETIC TRAIT; GENETIC VARIABILITY; GENOMICS; HAPLOTYPE; HEART FUNCTION; HUMAN; HYPOXIC ISCHEMIC ENCEPHALOPATHY; IMMUNE RESPONSE; LUNG ALVEOLUS SURFACE TENSION; LUNG DYSPLASIA; LUNG INJURY; LUNG VOLUME; NEUROPROTECTION; NEUTROPHIL; NONHUMAN; OXIDATIVE STRESS; PERINATAL ASPHYXIA; PREMATURE LABOR; PREMATURITY; RESPIRATORY TRACT DISEASE; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; ANIMAL; BRONCHOPULMONARY DYSPLASIA; LUNG DISEASES; METABOLISM; NEWBORN;

ANIMALS; ANTIOXIDANTS; BRONCHOPULMONARY DYSPLASIA; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; LUNG DISEASES; SUPEROXIDE DISMUTASE; SURFACE-ACTIVE AGENTS;

EID: 84900305495     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2014/721043     Document Type: Review

References (82)

1. Saugstad O. D., Oxidative stress in the newborn-a 30-year perspective. Biology of the Neonate 2005 88 3 228 236 2-s2.0-26444533396 10.1159/000087586 (Pubitemid 41433555)
2. Buonocore G., Perrone S., Tataranno M. L., Oxygen toxicity: chemistry and biology of reactive oxygen species. Seminars in Fetal and Neonatal Medicine 2010 15 4 186 190 2-s2.0-77955049244 10.1016/j.siny.2010.04.003
3. Kinsella J. P., Greenough A., Abman S. H., Bronchopulmonary dysplasia. The Lancet 2006 367 9520 1421 1431 2-s2.0-33646137788 10.1016/S0140-6736(06) 68615-7
4. Perrone S., Tataranno M. L., Negro S., Longini M., Marzocchi B., Proietti F., Iacoponi F., Capitani S., Buonocore Giuseppe G., Early identification of the risk for free radical-related diseases in preterm newborns. Early Human Development 2010 86 4 241 244 2-s2.0-77953293606 10.1016/j.earlhumdev.2010.03. 008
5. Perrone S., Negro S., Tataranno M. L., Buonocore G., Oxidative stress and antioxidant strategies in newborns. Journal of Maternal-Fetal and Neonatal Medicine 2010 23 3 63 65 2-s2.0-77957945275 10.3109/14767058.2010.509940
6. Vento M., Moro M., Escrig R., Arruza L., Villar G., Izquierdo I., Roberts L. J. II, Arduini A., Escobar J. J., Sastre J., Asensi M. A., Preterm resuscitation with low oxygen causes less oxidative stress, inflammation, and chronic lung disease. Pediatrics 2009 124 3 e439 e449 2-s2.0-70349252005 10.1542/peds.2009-0434
7. Saugstad O. D., Ramji S., Soll R. F., Vento M., Resuscitation of newborn infants with 21% or 100% oxygen: an updated systematic review and meta-analysis. Neonatology 2008 94 3 176 182 2-s2.0-53549109977 10.1159/000143397
8. Perlman J. M., Wyllie J., Kattwinkel J., Atkins D. L., Chameides L., Goldsmith J. P., Guinsburg R., Hazinski M. F., Morley C., Richmond S., Simon W. M., Singhal N., Szyld E., Tamura M., Velaphi S., Neonatal resuscitation chapter collaborators. Part 11: Neonatal resuscitation: 2010 International consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations. Circulation 2010 122 supplement 16 S516 S538 2-s2.0-78149276276 10.1161/CIRCULATIONAHA.110.971127
9. Vento M., Escobar J., Cernada M., Escrig R., Aguar M., The use and misuse of oxygen during the neonatal period. Clinics in Perinatology 2012 39 1 165 176 2-s2.0-84857088282 10.1016/j.clp.2011.12.014
10. Dawson J. A., Kamlin C. O. F., Vento M., Wong C., Cole T. J., Donath S. M., Davis P. G., Morley C. J., Defining the reference range for oxygen saturation for infants after birth. Pediatrics 2010 125 6 e1340 e1347 2-s2.0-77953062840 10.1542/peds.2009-1510
11. Vento M., Cubells E., Escobar J. J., Escrig R., Aguar M., Brugada M., Cernada M., Saénz P., Izquierdo I., Oxygen saturation after birth in preterm infants treated with continuous positive airway pressure and air: assessment of gender differences and comparison with a published nomogram. Archives of Disease in Childhood. Fetal and Neonatal Edition 2013 98 3 F228 F232 10.1136/archdischild-2012-302369
12. Dawson J. A., Vento M., Finer N. N., Rich W., Saugstad O. D., Morley C. J., Davis P. G., Managing oxygen therapy during delivery room stabilization of preterm infants. Journal of Pediatrics 2012 160 1 158 161 2-s2.0-82955207521 10.1016/j.jpeds.2011.07.045
13. Coalson J. J., Pathology of new bronchopulmonary dysplasia. Seminars in Neonatology 2003 8 1 73 81 2-s2.0-0037300312 10.1016/S1084-2756(02)00193-8 (Pubitemid 36356495)
14. Gitto E., Pellegrino S., D'Arrigo S., Barberi I., Reiter R. J., Oxidative stress in resuscitation and in ventilation of newborns. European Respiratory Journal 2009 34 6 1461 1469 2-s2.0-73249130392 10.1183/09031936.00032809
15. Frank L., Sosenko I. R., Failure of premature rabbits to increase antioxidant enzymes during hyperoxic exposure: increased susceptibility to pulmonary oxygen toxicity compared with term rabbits. Pediatric Research 1991 29 3 292 296 2-s2.0-0026031305
16. Morton R. L., Das K. C., Guo X., Iklé D. N., White C. W., Effect of oxygen on lung superoxide dismutase activities in premature baboons with bronchopulmonary dysplasia. American Journal of Physiology-Lung Cellular and Molecular Physiology 1999 276 1 L64 L74 2-s2.0-0032919278 (Pubitemid 29061666)
17. Lurie S., Matas Z., Boaz M., Fux A., Golan A., Sadan O., Different degrees of fetal oxidative stress in elective and emergent cesarean section. Neonatology 2007 92 2 111 115 2-s2.0-34547735554 10.1159/000100965 (Pubitemid 47230737)
18. Vento M., Asensi M., Sastre J., Lloret A., García-Sala F., Viña J., Oxidative stress in asphyxiated term infants resuscitated with 100% oxygen. Journal of Pediatrics 2003 142 3 240 246 2-s2.0-0037342239 10.1067/mpd.2003.91 (Pubitemid 36338004)
19. Kumar A., Ramakrishna S. V. K., Basu S., Rao G. R. K., Oxidative stress in perinatal asphyxia. Pediatric Neurology 2008 38 3 181 185 2-s2.0-38949130787 10.1016/j.pediatrneurol.2007.10.008 (Pubitemid 351221225)
20. Stigger F., Lovatel G., Marques M., Bertoldi K., Moysés F., Elsner V., Siqueira I. R., Achaval M., Marcuzzo S., Inflammatory response and oxidative stress in developing rat brain and its consequences on motor behavior following maternal administration of LPS and perinatal anoxia. International Journal of Developmental Neuroscience 2013 31 8 820 827 10.1016/j.ijdevneu.2013. 10.003
21. Capani F., Loidl C. F., Aguirre F., Piehl L., Facorro G., Hager A., De Paoli T., Farach H., Pecci-Saavedra J., Changes in reactive oxygen species (ROS) production in rat brain during global perinatal asphyxia: an ESR study. Brain Research 2001 914 1-2 204 207 2-s2.0-0035964780 10.1016/S0006-8993(01)02781-0 (Pubitemid 32905447)
22. Ciccoli L., Rossi V., Leoncini S., Signorini C., Paffetti P., Bracci R., Buonocore G., Comporti M., Iron release in erythrocytes and plasma non protein-bound iron in hypoxic and non hypoxic newborns. Free Radical Research 2003 37 1 51 58 2-s2.0-0037248796 10.1080/1071576021000032122 (Pubitemid 36124330)
23. Ciccoli L., Rossi V., Leoncini S., Signorini C., Blanco-Garcia J., Aldinucci C., Buonocore G., Comporti M., Iron release, superoxide production and binding of autologous IgG to band 3 dimers in newborn and adult erythrocytes exposed to hypoxia and hypoxia-reoxygenation. Biochimica et Biophysica Acta-General Subjects 2004 1672 3 203 213 2-s2.0-2942620602 10.1016/j.bbagen. 2004.04.003
24. Marzocchi B., Ciccoli L., Tani C., Leoncini S., Rossi V., Bini L., Perrone S., Buonocore G., Hypoxia-induced post-translational changes in red blood cell protein map of newborns. Pediatric Research 2005 58 4 660 665 2-s2.0-25444497979 10.1203/01.PDR.0000180545.24457.AC (Pubitemid 41368893)
25. Perrone S., Tataranno M. L., Stazzoni G., Del Vecchio A., Buonocore G., Oxidative injury in neonatal erythrocytes. Journal of Maternal-Fetal and Neonatal Medicine 2012 25 supplement 5 104 108
26. Gill R. S., Lee T. F., Manouchehri N., Liu J. Q., Lopaschuk G., Bigam D. L., Cheung P. Y., Postresuscitation cyclosporine treatment attenuates myocardial and cardiac mitochondrial injury in newborn piglets with asphyxia- reoxygenation. Critical Care Medicine 2013 41 4 1069 1074
27. Labossiere J. R., Pelletier J. S., Ali M. A., Thiesen A., Schulz R., Bigam D. L., Cheung P. Y., Postresuscitation administration of doxycycline preserves cardiac contractile function in hypoxia-reoxygenation injury of newborn piglets. Critical Care Medicine 2013
28. Cheung P. Y., Miedzyblocki M., Lee T. F., Bigam D. L., Effects of post-resuscitation administration with sodium hydrosulfide on cardiac recovery in hypoxia-reoxygenated newborn piglets. European Journal of Pharmacology 2013 718 1-3 74 80 10.1016/j.ejphar.2013.09.017
29. Wang Z., Zhao H., Peng S., Zuo Z., Intranasal pyrrolidine dithiocarbamate decreases brain inflammatory mediators and provides neuroprotection after brain hypoxia-ischemia in neonatal rats. Experimental Neurology 2013 249 74 82 10.1016/j.expneurol.2013.08.006
30. Gill R. S., Lee T. F., Liu J. Q., Chaudhary H., Brocks D. R., Bigam D. L., Cheung P. Y., Cyclosporine treatment reduces oxygen free radical generation and oxidative stress in the brain of hypoxia-reoxygenated newborn piglets. PLoS ONE 2012 7 e40471
31. Slaughter J. L., Stenger M. R., Reagan P. B., Variation in the use of diuretic therapy for infants with bronchopulmonary dysplasia. Pediatrics 2013 131 4 716 723 10.1542/peds.2012-1835
32. Rodriguez C., Mayo J. C., Sainz R. M., Antolín I., Herrera F., Martín V., Reiter R. J., Regulation of antioxidant enzymes: a significant role for melatonin. Journal of Pineal Research 2004 36 1 1 9 2-s2.0-1642562820 10.1046/j.1600-079X.2003.00092.x (Pubitemid 38130283)
33. Tan D. X., Manchester L. C., Terron M. P., Flores L. J., Reiter R. J., One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species? Journal of Pineal Research 2007 42 1 28 42 2-s2.0-33845536018 10.1111/j.1600-079X.2006.00407.x (Pubitemid 44924323)
34. Robertson N. J., Faulkner S., Fleiss B., Bainbridge A., Andorka C., Price D., Powell E., Lecky-Thompson L., Thei L., Chandrasekaran M., Hristova M., Cady E. B., Gressens P., Golay X., Raivich G., Melatonin augments hypothermic neuroprotection in a perinatal asphyxia model. Brain 2013 136 1 90 105 10.1093/brain/aws285
35. Gitto E., Reiter R. J., Cordaro S. P., La Rosa M., Chiurazzi P., Trimarchi G., Gitto P., Calabrò M. P., Barberi I., Oxidative and inflammatory parameters in respiratory distress syndrome of preterm newborns: beneficial effects of melatonin. American Journal of Perinatology 2004 21 4 209 216 2-s2.0-2342476969 10.1055/s-2004-828610 (Pubitemid 38691520)
36. Gitto E., Reiter R. J., Amodio A., Romeo C., Cuzzocrea E., Sabatino G., Buonocore G., Cordaro V., Trimarchi G., Barberi I., Early indicators of chronic lung disease in preterm infants with respiratory distress syndrome and their inhibition by melatonin. Journal of Pineal Research 2004 36 4 250 255 2-s2.0-11144355886 10.1111/j.1600-079X.2004.00124.x (Pubitemid 38530472)
37. Gitto E., Karbownik M., Reiter R. J., Xian Tan D., Cuzzocrea S., Chiurazzi P., Cordaro S., Corona G., Trimarchi G., Barberi I., Effects of melatonin treatment in septic newborns. Pediatric Research 2001 50 6 756 760 2-s2.0-0035204767 (Pubitemid 33121647)
38. Pan L., Fu J., Xue X., Xu W., Zhou P., Wei B., Melatonin protects against oxidative damage in a neonatal rat model of bronchopulmonary dysplasia. World Journal of Pediatrics 2009 5 3 216 221 2-s2.0-69249196022 10.1007/s12519-009- 0041-2
39. Rosenfeld W. N., Davis J. M., Parton L., Richter S. E., Price A., Flaster E., Kassem N., Safety and pharmacokinetics of recombinant human superoxide dismutase administered intratracheally to premature neonates with respiratory distress syndrome. Pediatrics 1996 97 6 811 817 2-s2.0-0030047376 (Pubitemid 26000001)
40. Davis J. M., Rosenfeld W. N., Richter S. E., Parad R., Gewolb I. H., Spitzer A. R., Carlo W. A., Couser R. J., Price A., Flaster E., Kassem N., Edwards L., Tierney J., Horowitz S., Safety and pharmacokinetics of multiple doses of recombinant human CuZn superoxide dismutase administered intratracheally to premature neonates with respiratory distress syndrome. Pediatrics 1997 100 1 24 30 2-s2.0-18544401753 10.1542/peds.100.1.24 (Pubitemid 27291004)
41. Davis J. M., Richter S. E., Biswas S., Rosenfeld W. N., Parton L., Gewolb I. H., Parad R., Carlo W., Couser R. J., Baumgart S., Atluru V., Salerno L., Kassem N., Long-term follow-up of premature infants treated with prophylactic, intratracheal recombinant human CuZn superoxide dismutase. Journal of Perinatology 2000 20 4 213 216 2-s2.0-0034201693
42. Davis J. M., Parad R. B., Michele T., Allred E., Price A., Rosenfeld W., Pulmonary outcome at 1 year corrected age in premature infants treated at birth with recombinant human CuZn superoxide dismutase. Pediatrics 2003 111 3 469 476 2-s2.0-0344375086 10.1542/peds.111.3.469 (Pubitemid 36330700)
43. Dani C., Poggi C., The role of genetic polymorphisms of antioxidant enzymes and potential antioxidant therapies in neonatal lung disease. Antioxidants & Redox Signaling 2014
44. Turrens J. F., Crapo J. D., Freeman B. A., Protection against oxygen toxicity by intravenous injection of liposome-entrapped catalase and superoxide dismutase. Journal of Clinical Investigation 1984 73 1 87 95 2-s2.0-0021352122 (Pubitemid 14222651)
45. Padmanabhan R. V., Gudapaty R., Liener I. E., Protection against pulmonary oxygen toxicity in rats by the intratracheal administration of liposome-encapsulated superoxide dismutase or catalase. American Review of Respiratory Disease 1985 132 1 164 167 2-s2.0-0021875049 (Pubitemid 15026206)
46. Davis J. M., Rosenfeld W. N., Sanders R. J., Gonenne A., Prophylactic effects of recombinant human superoxide dismutase in neonatal lung injury. Journal of Applied Physiology 1993 74 5 2234 2241 2-s2.0-0027252139 (Pubitemid 23157045)
47. Barnard M. L., Baker R. R., Matalon S., Mitigation of oxidant injury to lung microvasculature by intratracheal instillation of antioxidant enzymes. American Journal of Physiology-Lung Cellular and Molecular Physiology 1993 265 4 L340 L345 2-s2.0-0027485799 (Pubitemid 23321732)
48. Ahmed M. N., Suliman H. B., Folz R. J., Nozik-Grayck E., Golson M. L., Mason S. N., Auten R. L., Extracellular superoxide dismutase protects lung development in hyperoxia-exposed newborn mice. American Journal of Respiratory and Critical Care Medicine 2003 167 3 400 405 2-s2.0-0037320049 10.1164/rccm.200202-108OC (Pubitemid 36216423)
49. Auten R. L., O'Reilly M. A., Oury T. D., Nozik-Grayck E., Whorton M. H., Transgenic extracellular superoxide dismutase protects postnatal alveolar epithelial proliferation and development during hyperoxia. American Journal of Physiology-Lung Cellular and Molecular Physiology 2006 290 1 L32 L40 2-s2.0-33644805695 10.1152/ajplung.00133.2005
50. Ahmed M. N., Codipilly C., Hogg N., Auten R. L., The protective effect of overexpression of extracellular superoxide dismutase on nitric oxide bioavailability in the lung after exposure to hyperoxia stress. Experimental Lung Research 2011 37 1 10 17 2-s2.0-79251487224 10.3109/01902148.2010.497893
51. Min J. H., Codipilly C. N., Nasim S., Miller E. J., Ahmed M. N., Synergistic protection against hyperoxia-induced lung injury by neutrophils blockade and EC-SOD overexpression. Respiratory Research 2012 13 58 10.1186/1465-9921-13-58
52. Carlsson L. M., Jonsson J., Edlund T., Marklund S. L., Mice lacking extracellular superoxide dismutase are more sensitive to hyperoxia. Proceedings of the National Academy of Sciences of the United States of America 1995 92 14 6264 6268 2-s2.0-0029064709 10.1073/pnas.92.14.6264
53. Wispe J. R., Warner B. B., Clark J. C., Dey C. R., Neuman J., Glasser S. W., Crapo J. D., Chang L.-Y., Whitsett J. A., Human Mn-superoxide dismutase in pulmonary epithelial cells of transgenic mice confers protection from oxygen injury. Journal of Biological Chemistry 1992 267 33 23937 23941 2-s2.0-0027067905 (Pubitemid 23088207)
54. Folz R. J., Abushamaa A. M., Suliman H. B., Extracellular superoxide dismutase in the airways of transgenic mice reduces inflammation and attenuates lung toxicity following hyperoxia. Journal of Clinical Investigation 1999 103 7 1055 1066 2-s2.0-0032954805 (Pubitemid 29169614)
55. Holst D., Garnier Y., Preterm birth and inflammation-The role of genetic polymorphisms. European Journal of Obstetrics Gynecology and Reproductive Biology 2008 141 1 3 9 2-s2.0-54849417165 10.1016/j.ejogrb.2008.07.020
56. Poggi C., Giusti B., Vestrini A., Pasquini E., Abbate R., Dani C., Genetic polymorphisms of antioxidant enzymes in preterm infants. Journal of Maternal-Fetal and Neonatal Medicine 2012 25 supplement 4 131 134
57. Giusti B., Vestrini A., Poggi C., Magi A., Pasquini E., Abbate R., Dani C., Genetic polymorphisms of antioxidant enzymes as risk factors for oxidative stress-associated complications in preterm infants. Free Radical Research 2012 46 9 1130 1139 10.3109/10715762.2012.692787
58. Esplin M. S., Preterm birth: a review of genetic factors and future directions for genetic study. Obstetrical and Gynecological Survey 2006 61 12 800 806 2-s2.0-33751333649 10.1097/01.ogx.0000248747.52343.5f (Pubitemid 44808702)
59. Usuda T., Kobayashi T., Sakakibara S., Kobayashi A., Kaneko T., Wada M., Onozuka J., Numata O., Torigoe K., Yamazaki H., Sato T., Nagayama Y., Uchiyama M., Interleukin-6 polymorphism and bronchopulmonary dysplasia risk in very low-birthweight infants. Pediatrics International 2012 54 4 471 475 10.1111/j.1442-200X.2012.03625.x
60. Bokodi G., Derzbach L., Bányász I., Tulassay T., Vásárhelyi B., Association of interferon γ T+874A and interleukin 12 p40 promoter CTCTAA/GC polymorphism with the need for respiratory support and perinatal complications in low birthweight neonates. Archives of Disease in Childhood: Fetal and Neonatal Edition 2007 92 1 F25 F29 2-s2.0-33846337879 10.1136/adc.2005.086421 (Pubitemid 46132962)
61. Sampath V., Garland J. S., Le M., Patel A. L., Konduri G. G., Cohen J. D., Simpson P. M., Hines R. N., A TLR5 (g.1174C > T) variant that encodes a stop codon (R392X) is associated with bronchopulmonary dysplasia. Pediatric Pulmonology 2012 47 5 460 468 2-s2.0-84859845998 10.1002/ppul.21568
62. Derzbach L., Bokodi G., Treszl A., Vásárhelyi B., Nobilis A., Rigó J. Jr., Selectin polymorphisms and perinatal morbidity in low-birthweight infants. Acta Paediatrica, International Journal of Paediatrics 2006 95 10 1213 1217 2-s2.0-33748880851 10.1080/08035250600575404 (Pubitemid 44423185)
63. Prencipe G., Auriti C., Inglese R., Devito R., Ronchetti M. P., Seganti G., Ravà L., Orzalesi M., De Benedetti F., A polymorphism in the macrophage migration inhibitory factor promoter is associated with bronchopulmonary dysplasia. Pediatric Research 2011 69 2 142 147 2-s2.0-79951628207 10.1203/PDR.0b013e3182042496
64. Hadchouel A., Decobert F., Franco-Montoya M., Halphen I., Jarreau P., Boucherat O., Martin E., Benachi A., Amselem S., Bourbon J., Danan C., Delacourt C., Matrix metalloproteinase gene polymorphisms and bronchopulmonary dysplasia: identification of MMP16 as a new player in lung development. PLoS ONE 2008 3 9 2-s2.0-52649167879 10.1371/journal.pone.0003188 e3188
65. Strassberg S. S., Cristea I. A., Qian D., Parton L. A., Single nucleotide polymorphisms of tumor necrosis factor- α and the susceptibility to bronchopulmonary dysplasia. Pediatric Pulmonology 2007 42 1 29 36 2-s2.0-33846155242 10.1002/ppul.20526 (Pubitemid 46080150)
66. Manar M. H., Brown M. R., Gauthier T. W., Brown L. A. S., Association of glutathione-S-transferase-P1 (GST-P1) polymorphisms with bronchopulmonary dysplasia. Journal of Perinatology 2004 24 1 30 35 2-s2.0-0742306416 10.1038/sj.jp.7211020 (Pubitemid 38159800)
67. Ramanathan R., Choosing a right surfactant for respiratory distress syndrome treatment. Neonatology 2008 95 1 1 5 2-s2.0-52849114019 10.1159/000151749
68. Dani C., Buonocore G., Longini M., Felici C., Rodriguez A., Corsini I., Rubaltelli F. F., Superoxide dismutase and catalase activity in naturally derived commercial surfactants. Pediatric Pulmonology 2009 44 11 1125 1131 2-s2.0-72449161633 10.1002/ppul.21116
69. Matalon S., Wright J. R., Surfactant proteins and inflammation: the Yin and the Yang. American Journal of Respiratory Cell and Molecular Biology 2004 31 6 585 586 2-s2.0-9744227883 10.1165/rcmb.F286 (Pubitemid 39587486)
70. Matalon S., Holm B. A., Baker R. R., Whitfield M. K., Freeman B. A., Characterization of antioxidant activities of pulmonary surfactant mixtures. Biochimica et Biophysica Acta-General Subjects 1990 1035 2 121 127 2-s2.0-0024997221 10.1016/0304-4165(90)90105-6 (Pubitemid 20251737)
71. Merritt T. A., Hallman M., Holcomb K., Human surfactant treatment of severe respiratory distress syndrome: pulmonary effluent indicators of lung inflammation. Journal of Pediatrics 1986 108 5 741 748 2-s2.0-0022460074 (Pubitemid 16064126)
72. Nieves-Cruz B., Rivera A., Cifuentes J., Pataki G., Matalon S., Carlo W. A., Tanswell A. K., Freeman B., Clinical surfactant preparations mediate SOD and catalase uptake by type II cells and lung tissue. American Journal of Physiology-Lung Cellular and Molecular Physiology 1996 270 4 L659 L667 2-s2.0-0029871036
73. Walther F. J., David-Cu R., Lopez S. L., Antioxidant-surfactant liposomes mitigate hyperoxic lung injury in premature rabbits. American Journal of Physiology-Lung Cellular and Molecular Physiology 1995 269 5 L613 L617 2-s2.0-0028844530
74. Rüdiger M., Tölle A., Meier W., Rüstow B., Naturally derived commercial surfactants differ in composition of surfactant lipids and in surface viscosity. American Journal of Physiology-Lung Cellular and Molecular Physiology 2005 288 L379 L383 (Pubitemid 40105377)
75. Zoeller R. A., Morand O. H., Raetz C. R. H., A possible role for plasmalogens in protecting animal cells against photosensitized killing. Journal of Biological Chemistry 1988 263 23 11590 11596 2-s2.0-0023782245
76. Jürgens G., Fell A., Ledinski G., Chen Q., Paltauf F., Delay of copper-catalyzed oxidation of low density lipoprotein by in vitro enrichment with choline or ethanolamine plasmalogens. Chemistry and Physics of Lipids 1995 77 1 25 31 2-s2.0-0029148689 10.1016/0009-3084(95)02451-N
77. Rüdiger M., Von Baehr A., Haupt R., Wauer R. R., Rüstow B., Preterm infants with high polyunsaturated fatty acid and plasmalogen content in tracheal aspirates develop bronchopulmonary dysplasia less often. Critical Care Medicine 2000 28 5 1572 1577 2-s2.0-0034127157 (Pubitemid 30324542)
78. Haagsman H. P., Hogenkamp A., Van Eijk M., Veldhuizen E. J. A., Surfactant collectins and innate immunity. Neonatology 2008 93 4 288 294 2-s2.0-44849090083 10.1159/000121454 (Pubitemid 351799112)
79. Matalon S., Shrestha K., Kirk M., Waldheuser S., McDonald B., Smith K., Gao Z., Belaaouaj A., Crouch E. C., Modification of surfactant protein D by reactive oxygen-nitrogen intermediates is accompanied by loss of aggregating activity, in vitro and in vivo. FASEB Journal 2009 23 5 1415 1430 2-s2.0-68749102352 10.1096/fj.08-120568
80. Wu Y., Adam S., Hamann L., Heine H., Ulmer A. J., Buwitt-Beckmann U., Stamme C., Accumulation of inhibitory B- α as a mechanism contributing to the anti-inflammatory effects of surfactant protein-A. American Journal of Respiratory Cell and Molecular Biology 2004 31 6 587 594 2-s2.0-9744232082 10.1165/rcmb.2004-0003OC (Pubitemid 39587487)
81. Kotecha S., Davies P. L., Clark H. W., McGreal E. P., Increased prevalence of low oligomeric state surfactant protein D with restricted lectin activity in bronchoalveolar lavage fluid from preterm infants. Thorax 2013 68 5 460 467 10.1136/thoraxjnl-2012-202729
82. Ryckman K. K., Dagle J. M., Kelsey K., Momany A. M., Murray J. C., Genetic associations of surfactant protein D and angiotensin-converting enzyme with lung disease in preterm neonates. Journal of Perinatology 2012 32 5 349 355 2-s2.0-84860361734 10.1038/jp.2011.104